A detailed history of Washington Trust Advisors, Inc. transactions in Insmed Inc stock. As of the latest transaction made, Washington Trust Advisors, Inc. holds 211 shares of INSM stock, worth $14,770. This represents 0.0% of its overall portfolio holdings.

Number of Shares
211
Previous 211 -0.0%
Holding current value
$14,770
Previous $6,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 05, 2022

BUY
$20.42 - $28.13 $1,123 - $1,547
55 Added 35.26%
211 $5,000
Q4 2021

Feb 11, 2022

BUY
$25.89 - $33.45 $4,038 - $5,218
156 New
156 $4,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.48B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Washington Trust Advisors, Inc. Portfolio

Follow Washington Trust Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust Advisors, Inc. with notifications on news.